
The American Society of Breast Surgeons (ASBrS) is pleased to offer Industry Events to the breast surgery community. Webinars are educational programs sponsored and funded by an outside organization, independently organized, and offered, and have been made possible through marketing support and advertising fees. Content is updated as programming details are received. See below for Upcoming Events and on-demand events: 2022, 2021 & 2020.
Interested in Supporting an Activity or Webinar?
Please contact Marti Boyer at mboyer@breastsurgeons.org.
The following industry activities are supported by specific companies through marketing grants and advertising fees. They are not part of the official education program of the ASBrS, and most events are free to all members. By clicking the links posted below, please understand you may leave the ASBrS website and go to a website not operated by the Society.
October 13–15, 2022
Australasian International Breast Congress (AIBC)
Overview:
On October 13-15, 2022, the Australasian Society for Breast Disease (ASBD), World Congress on Controversies in Breast Cancer (CoBrCa) and Breast Surgeons of Australia and New Zealand (BreastSurgANZ), will hold an international congress focusing on controversial issues in breast diseases including presentations, debates and discussions. For more information, visit aib-congress.org.
Learn More:
2022 Events on Demand
ImpediMed
PreludeDx
ImpediMed
PREVENT Meets Primary Endpoint:
A Detailed Look at the Practice-Changing Results and Real-World Experience with Breast Cancer-Related Lymphedema Prevention Cancer Care
Description:
PREVENT, the largest randomized clinical trial to assess lymphedema prevention, met its primary endpoint. Join our panel of experts as they debate the recently published results and implications for the future of breast cancer care. Topics covered will include the importance of early lymphedema detection and intervention, supporting clinical evidence, and real-world experience with clinical implementation. Discover how providing your patients with a lymphedema prevention program provides optimal patient care and can positively impact your practice.
Moderated By:
- Dr. Pat Whitworth
Director
Nashville Breast Center
Faculty:
- Dr. Beth DuPree
Breast Surgeon - Dr. Manpreet Kohli
Breast Surgeon
Breast Program Director Monmouth Medical Center - Dr. Chirag Shah
Co-Director Comprehensive Breast Program
Director of Breast Cancer Radiation Oncology and Director of Clinical Research, Department of Radiation Oncology, Cleveland Clinic
Educational Objectives:
- Understand the latest evidence from the PREVENT trial
- Discover the benefits of identifying and treating lymphedema at the subclinical stage
- Learn the best practices and economics for implementing a lymphedema prevention program
PreludeDx
Newly Published Data Review of DCISionRT Randomized SweDCIS Results and the Clinical Utility for Oncoplastic Surgical Planning
Description:
Join us for a published data review of the highly anticipated DCISionRT validation results in the randomized SweDCIS patient cohort. Practicing physicians will be discussing implications of this new data and the clinical utility of DCISionRT in minimizing over- and under-treatment of DCIS patients. There will be interactive discussions about meaningful application of DCISionRT into surgical practice and real-world patient case studies regarding oncoplastic surgical planning.
Faculty:
- Anne Peled, MD
Co-Director, Sutter CPMC Breast Cancer Program - Karen Barbosa, DO, FACOS
Breast Surgeon and Oncoplastic Surgeon and Medical Director, TidalHealth Delaware Breast Cancer Program - Pat Whitworth, MD, FACS
Breast Surgical Oncology Specialist, Director of the Nashville Breast Center - Chirag Shah, MD
Co-Director of the Comprehensive Breast Program, Cleveland Clinic - Troy Bremer, PhD
Founder and CSO of PreludeDx
For More Information:
Contact alindsay@preludedx.com, cdunn@preludedx.com
2021 Events on Demand
3M+KCI
Agendia
- A Case-Based Discussion of Integrating MammaPrint and BluePrint into Treatment Planning for Patients with Early Stage Breast Cancer
- A New Paradigm in Treatment Planning
- Genomic Profiling of Early Stage Breast Cancer: Expanding Applications to Improve Outcomes
Ambry Genetics
Bayer
Cardinal Health
Endomag
Exact Sciences
Hologic
- The Reconstructive Lumpectomy™: Beyond the Fundamentals–Techniques for the Breast Surgeon
- Updates and Education on the Principles and Practice of BioZorb® 3D Marker Utilization
Medtronic
- Insights from the Nipple Sparing Mastectomy Registry & Related Trending Topics
- Mitigating Risks & Complications in Nipple Sparing Mastectomies
Mammotome
Merit Medical
- Advanced Utilization of SCOUT® Radar Localization for Breast Cancer Surgery
- Post-COVID Strategies to Optimize Breast Cancer Care
- The Preferred Localization Solution to Treat More Patients: SCOUT
Pacira BioSciences, Inc.
Perimeter Medical Imaging AI, Inc.
- Is OCT the Next Game Changer in Margin Visualization?
- Next Generation in Surgical Specimen Imaging with Future AI Enhancements
3M+KCI
22nd Annual Meeting Symposium
Minimizing Post-operative Complications Following Major Breast Surgery
Description:
Please join us for a case-based discussion on innovative solutions that may minimize complications after challenging breast surgery cases. Contact Alexandra Castillo at acastillo8@mmm.com.
Agendia
22nd Annual Meeting Symposium
A Case-Based Discussion of Integrating MammaPrint and BluePrint into Treatment Planning for Patients with Early Stage Breast Cancer
Description:
This symposium will feature a case-based discussion of Mammaprint and Blueprint's clinical utility for patients with Early-Stage Breast Cancer. Pat Whitworth, MD, and William Audeh, MD, will discuss real world evidence and published clinical data in the context of patient care. Attendees will participate in an interactive Q&A at the end of the presentation.
Agendia
A New Paradigm in Treatment Planning: Integrating Molecular Subtyping as Part of Comprehensive Genomic Profiling into Routine Clinical Care for Patients with Breast Cancer
Presenter:
- William Audeh, MD
Chief Medical Officer, Agendia
Discussant:
- James Pellicane, MD
Director of Breast Oncology, Bon Secours Cancer Institute
For More Information:
Contact Israel Madera at israel.madera@agendia.com.
Agendia
Genomic Profiling of Early Stage Breast Cancer: Expanding Applications to Improve Outcomes
Description
This webinar will empower you with data demonstrating the utility of Agendia’s assays, MammaPrint® and BluePrint®, for patients with breast cancer. Review the latest data and learn about the real-world impact of MammaPrint and BluePrint. Please join us for an informative, interactive webinar.
Ambry Genetics
Expanding Surgical Patient Reach: Earlier Detection through Integration of an End-to-End Solution
Description:
Join us as we discuss how to strengthen the patient and provider journey toward an individualized treatment plan. The CARE Program™ provides an end-to-end solution that can help identify high-risk patients earlier for potential proactive medical management and preventative procedures.
Brochure:
Speakers:
- Anjali Date, MD
Sheila R. Veloz Breast Center Lead Interpreting Physician - Mari Shay, BSN, RN
Sheila R. Veloz Breast Center Manager, Women’s Imaging Services - Kory Jasperson, MS, CGC
Director, Clinical Services, Ambry Genetics
Bayer
Risk Stratified Breast Screening
Description:
Dr. Gillian Newstead (MD, FACR), Director of Global Breast Imaging at University of Chicago, will be talking about Risk Stratified Breast Screening and discussing the importance of breast density. She will share recommendations from the American College of Radiology and the American Society of Breast Surgeons and highlight the importance of supplemental Breast MRI screening for women with specific high risk factors, including women with dense breast tissue.
For More Information:
Contact Lainey Kasian at lainey.kasian@bayer.com.
Cardinal Health
How to Navigate the Impact of COVID-19 on Your Breast Cancer Practice
Description:
In honor of Breast Cancer Awareness Month, we invite you to join a complimentary webinar led by Linda Han, MD, FACS, PPG, Director of Breast Oncology at the Parkview Cancer Institute, where she will discuss the impact of COVID-19 on breast cancer care. During this hour-long webinar we’ll walk through:
- How to screen safely
- Best practices for following guidelines
- The impact on cancer-related mortality
- And provide a forum for Dr. Han to answer your questions
About the Speaker:
- Linda Han, MD, FACS, PPG
Director of Breast Oncology
Parkview Cancer Institute
Dr. Han currently serves as the Director of Breast Oncology at Parkview Cancer Institute and Chief Surgery Quality and Optimization Officer for Parkview Health in Fort Wayne, Indiana. She continues to remain active in surgical education as an adjunct professor of clinical surgery and has received numerous teaching awards for excellence in resident and medical student education.
Endomag
22nd Annual Meeting Symposium
Tissue Localization – The Future is Paramagnetic
Description:
Presenting the latest data on seed localization, featuring results from iBRA-NET, the world’s largest multicenter seed localization study with over 1,000 patients and the latest findings for TAD with Magseed® from the University of Texas MD Anderson Cancer Center. This is followed by a roundtable Q&A and an exclusive sneak peek at the new Sentimag® Gen 3 platform. For more information, contact Mathew Stephens (mstephens@endomag.com) or Connor Jipps (cjipps@endomag.com).
Exact Sciences
22nd Annual Meeting Symposium
De-escalating Breast Cancer Surgery with Neoadjuvant Endocrine Therapy
Description:
Dr. Christy Russell, Sr. Director of Global Medical Affairs at Exact Sciences, and Dr. Susan Boolbol, System Chief of the Breast Surgical Oncology and Breast Program at Nuvance Health, discuss the utility of neoadjuvant endocrine therapy to de-escalate breast and axillary surgery in HR-positive, HER2-negative breast cancer patients. The presentation will also review data pertaining to biomarkers used to make neoadjuvant treatment decisions, including the Oncotype DX Breast Recurrence Score® test. For more information, contact Thomas Mallick (tmallick@exactsciences.com).
Hologic
The Reconstructive Lumpectomy™: Beyond the Fundamentals–Techniques for the Breast Surgeon
Description:
A Live Hologic Virtual Course featuring Cadaveric Assessment and Surgical Skills Advancement. Each of the three recorded sessions include lecture and case examples presented by renowned faculty, cadaveric demonstration of skills, introduction to technology, interactive panel discussion, and the opportunity to ask questions of the panel.
Brochure:
Topics Include:
- Applied Breast Anatomy
- Aesthetic Scar Placement
- Donut Mammoplasty and Modifications for all quadrants
- Managing Complications in Oncoplastic Breast Surgery
- Multi-Disciplinary Decision Making
Educational Objectives:
- Perform aesthetically state of the art surgeries with optimal outcomes
- Understand how technology can reduce re-excisions, returns to OR, and deliver state of the art treatment in an ever-changing health care climate
- Treat tumors in all quadrants without a plastic surgeon
- Have a strong fundamental understanding of breast anatomy and aesthetics to proceed with other training in Level II procedures
- Identify and spot red flags that would lead to poor outcomes
Criteria for Participation:
Practicing breast or general surgeons who perform breast cases, practicing radiologists and radiation oncologists also welcome. Hologic reserves the right to accept or decline any registration or request for attendance. Attendees are limited to those practicing surgery, radiology, or radiation oncology.
Hologic
22nd Annual Meeting Symposium
Updates and Education on the Principles and Practice of BioZorb® 3D Marker Utilization
Description:
Join the conversation with breast surgeons and a radiation oncologist as they discuss the role of a BioZorb® marker in a Reconstructive Lumpectomy™ surgery as well as the recent publication of the BioZorb® registry in the Annals of Surgical Oncology. Topics include communication with patients and practicing a multidisciplinary approach to patient care.
Faculty:
- Dr. Cary Kaufman
- Dr. Kiran Devisetty
- Dr. Ashley Richardson
- Dr. Lorraine Tafra
Mammotome
22nd Annual Meeting Symposium
Modernizing Axillary Management: Delayed SLNB for DCIS Patients
Description:
How can you spare up to 78% of high-risk DCIS patients axillary surgery? Join a panel of surgical experts as they discuss how they’re taking patient care to the next level with tailored axillary management procedures and sparing some patients SLNB.
- Roundtable Discussion
- Procedure Videos
- Downloadable Resources
Medtronic
Insights from the Nipple Sparing Mastectomy Registry & Related Trending Topics
Description:
Join our Faculty for a one-hour webinar as they take a closer look at the ASBrS Nipple Sparing Registry data. Jay Harness, MD will moderate a panel discussion with Shawna Willey, MD, Beth DuPree, MD and William Scarlett, DO as they review how data insights can drive improvement of care and reduce complications in Nipple Sparing Mastectomies. We encourage audience participation, discussion and questions at the end. Please join us for an informative, interactive webinar.
Brochure:
Objectives:
- Evaluate the Nipple Sparing Mastectomy Registry Data and discuss how the results can be used to influence patient outcomes.
- Review the science behind technologies that can help drive more efficient and effective care.
- Discuss breast reconstruction options, including the considerations for patient selection.
- Understand how to reduce complications using impact of technique, proper incision placements and tumescence in surgery.
Target Audience:
- Breast Surgeons
- General Surgeons
- Plastic Surgeons
- Healthcare Providers
Faculty:
- Dr. Jay Harness
- Dr. Shawna Willey
- Dr. Beth DuPree
- Dr. William Scarlett
Questions:
Contact Kirsten Gonya at kirsten.m.gonya@medtronic.com.
Medtronic
22nd Annual Meeting Symposium
Mitigating Risks & Complications in Nipple Sparing Mastectomies
Description:
Join our Faculty, Shawna Willey, MD, William Scarlett, DO, and Jay Harness, MD, for a one-hour virtual event as they take a closer look at Nipple Sparing Mastectomy risks & complications. They will discuss the importance of patient selection, the complication rates associated with various measurements, surgical approaches, and the benefits of the tools and technologies used in NSM. We encourage audience participation, discussion and questions at the end. For more information, contact Kirsten Gonya (kirsten.m.gonya@medtronic.com).
Merit Medical
Think Wire-Free w/ Dr. Madrigrano and Dr. Murphy. Advanced Utilization of SCOUT® Radar Localization for Breast Cancer Surgery
Presentation Highlights:
- Utility for Oncoplastic Approaches
- Targeted Axillary Dissection
- Utility of Access Guide for Small Incisions
- Case Reviews
Merit Medical
Think Wire-Free w/ Dr. Barry Rosen and Dr. Mary Hayes. Post-COVID Strategies to Optimize Breast Cancer Care: A Patient-Centered Model
Description:
Join Advocate Health’s Barry Rosen, MD, and Memorial Healthcare’s Mary Hayes, MD, to learn how they uniquely employed SCOUT Radar Localization throughout the patient care continuum and throughout their systems to achieve streamlined, patient-centered care.
Brochure:
Presentation Highlights:
- Cost and clinical advantages derived from going Wire-Free
- Reducing patient facility visits through localizing with SCOUT at biopsy & data review
- Clinical utility of SCOUT for Mastectomy and Oncoplastic approaches
Speakers:
- Barry Rosen, MD, FACS
Breast Team Leader, Advocate Healthcare, Chicago, IL
Managing Partner, Targeted Medical Education (TME)
Assistant Professor of Surgery Univeristy of Illinois College of Medicine - Mary K. Hayes, MD
Former Medical Director and Chief of Women’s Imaging at Memorial Healthcare System and Envision
Merit Medical
22nd Annual Meeting Symposium
The Preferred Localization Solution to Treat More Patients: SCOUT
Description:
SCOUT Radar localization exclusively spans the care continuum from time of biopsy placement to Targeted Axillary Dissection to excellent surgical outcomes. Discover the state-of-the art localization techniques practiced by key opinion leaders from the Cleveland Clinic, Columbia University, University of Colorado, Intermountain Healthcare and the Advocate System.
Pacira BioSciences, Inc.
Optimizing Outpatient Breast Surgery: A Multidisciplinary Panel Discussion
Description:
The panel will evaluate critical factors in optimizing surgical results and recovery across in- and outpatient settings, including:
- Patient selection and engagement
- Communication, multimodal and culture change
- Integrating experience and techniques from plastic surgery
Moderated by:
- Shawna Willey, MD
Peterson Chair of Breast Cancer Research
Inova Schar Cancer Institute
Inova Fairfax Hospital
Panelists:
- Mark Brzezienski, MD
University of Tennessee Health Science Center
Professor of Plastic and Orthopedic Surgery
Chairman and Program Director Department of Plastic Surgery - Jeff Gonzales, MD
Staff Anesthesiologist
Parker Adventist Hospital - Stephanie Valente, DO
Breast Surgeon
Cleveland Clinic
Questions:
For questions, please contact Erin.Fitzpatrick@pacira.com.
Perimeter Medical Imaging AI, Inc.
Is OCT the Next Game Changer in Margin Visualization?
Description:
Join us as we present multiple patient cases using a new FDA-cleared intraoperative specimen imaging technology for real-time margin visualization of excised tissue and shaved margins with surgeons from three prestigious institutions involved in Perimeter’s clinical trials. This webinar provides a deeper dive on Optical Coherence Tomography (OCT) – an established, ultra high-resolution technology used in cardiology, dermatology and ophthalmology – and correlates OCT images to histopathology.
Brochure:
Speakers:
- Nina Tamirisa, MD
Assistant Professor, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX - Maryam Elmi, MD
Assistant Professor, Division of Surgical Oncology & Endocrine Surgery, University of Texas Health Science Center, San Antonio, TX - Stacey Carter, MD, FACS
Assistant Professor of Surgery, Division of Surgical Oncology, Breast Surgery Section, Baylor College of Medicine, Houston, TX
Contact Information:
For more information, contact Andrew Berkeley at aberkeley@perimetermed.com or sales@perimetermed.com or call 214‑845‑5154.
Perimeter Medical Imaging AI, Inc.
Next Generation in Surgical Specimen Imaging with Future AI Enhancements
Description:
Learn more about advancements in intraoperative specimen imaging. Optical Coherence Tomography (OCT), a high-resolution imaging modality commonly used in ophthalmology and cardiology, is ideally suited to visualizing margins during a surgical procedure. This webinar also includes insights into how Artificial Intelligence is moving towards the OR and Specimen Imaging.
Brochure:
Presentation Highlights
- Intraoperative Specimen Imaging and the Role of OCT
- OCT in the Operating Room and Case Reviews
- Applying to AI to OCT Specimen Imaging
Speakers:
- Hank Schmidt, MD, PhD
Associate Professor of Surgery, Mount Sinai School of Medicine, Dubin Breast Center, Tisch Cancer Institute, New York, NY - Beth DuPree, MD, FACS, ABOIM
Medical Director Oncology Service Line Centers of Northern Arizona at Northern Arizona Healthcare, AZ - Alastair Thompson, BSc (Hons), MBChB, MD, FRCS (Ed)
Professor and Chief, Section of Breast Surgery, Division of Surgical Oncology, Bayor College of Medicine
Contact Information:
For more information, contact Andrew Berkeley at aberkeley@perimetermed.com.
Educational Grants & Marketing Support
Marketing support for the ASBrS 2021 Virtual Education Series is provided by Agendia, Ambry Genetics, Cardinal Health, Genentech, Hologic, Mammotome, Medtronic, Merit Medical, Pacira BioSciences, Inc., Perimeter Medical Imaging AI, Inc., and Stryker.
2020 Events on Demand
Agendia
Exact Sciences Corporation
Hologic
Mammotome
- Implementing Wire-Free Localization & Radiation-Free SLNB
- Leveraging Your Biopsy Markers (Part One): From Placement to Surgery
- Leveraging Your Biopsy Markers (Part Two): Localization and Beyond
- Radiation-Free Targeted Axillary Dissection
Medtronic
Myriad Genetics, Inc.
PeerView Institute
Agendia
From NBRST to MINDACT: The Clinical Utility of BluePrint and MammaPrint in the Pre- and Post-Operative Treatment Settings
Presenter:
- Alberto Montero, MD; Director Breast Cancer Program, UH Seidman Cancer Center; Associate Professor, CWRU School of Medicine
Discussant:
- James Pellicane, MD; Director of Breast Oncology, Bon Secours Cancer Institute
Description:
Please join our webinar for an interactive discussion of comprehensive genomic profiling and how it can facilitate patient-centered care. Dr. Montero will provide updates on the NBRST and MINDACT clinical trials and discuss the utility of MammaPrint and BluePrint in the pre- and post-operative treatment settings with Dr. Pellicane. We look forward to an impactful webinar and welcome audience participation during the Q&A session.
For More Information:
Contact Israel Madera, israel.madera@agendia.com.
Exact Sciences (formerly Genomic Health, Inc.)
Less is More: De-escalation of Local and Systemic Therapy with the Breast Recurrence Score® Test
Presenters:
- Julia White, MD, Ohio State University Comprehensive Cancer Center
- Anthony Lucci, MD, University of Texas, MD Anderson Cancer Center
- Moderated by Christy Russell, MD, Exact Sciences
Hologic
Panel Discussion: Optimal Surgical Treatment of Breast Reconstruction & Localization with Cases
Description:
An interactive panel discussion designed to highlight optimal breast reconstruction, localization techniques, and radiation planning along with specimen radiography through examination of actual cases and outcomes. Participants will have an opportunity to ask questions, share perspectives and hear about the latest breast reconstruction methods from a multi-disciplinary team including surgery, radiology, and radiation oncology practicing in both academic and community-based centers.
Speakers:
- Karen Barbosa, DO, FACOS
Breast Surgeon
University of Maryland Shore Regional Health, Clark Comprehensive Breast Center Anthony Lucci, MD, FACS
Department of Breast Surgical Oncology, Division of Surgery
MD Anderson Cancer CenterJoshua Mondschein, MD, MSCI, DABR
Radiation Oncologist
Tennessee Oncology / Provisions Proton Therapy
For More Information:
Please contact MedEd-BSH@hologic.com.
Mammotome
Changing the Standard of Care for Breast Surgery: Implementing Wire-Free Localization & Radiation-Free SLNB
Description:
Learn how Dr. McGuire is implementing wire-free localization and radiation-free SLNB technology that is changing her patient flow and improving outcomes. Advanced techniques such as delayed SLNB are now options for her patients.
1 Category A CEU, ASRT Approved
Presenter:
- Kandace McGuire, MD, Virginia Commonwealth University
Mammotome
Leveraging Your Biopsy Markers (Part One): From Placement to Surgery
Description:
- Review how the latest trends in NACT and Endocrine Therapy are changing patient flow
- Learn how a marker can optimize patient care
- Review case studies
- Live Q&A
Mammotome
Leveraging Your Biopsy Markers (Part Two): Localization and Beyond
Description:
- Advanced techniques of localizing with ultrasound
- Review how the latest trends in NACT and Endocrine Therapy are changing patient flow
- Review case studies
- Live Q&A
Mammotome
Radiation-Free Targeted Axillary Dissection
Description:
Join Dr. Michael Alvarado as he discusses how to reduce your false negative rates with radiation-free targeted axillary dissection. Watch video demonstrations of Dr. Alvarado performing TAD and hear how using innovative localizing technology is improving outcomes for his patients.
Presenter:
- Michael Alvarado, MD, University of San Francisco
Medtronic
Let’s Talk About: The Pandemic’s Impact on Breast Surgery IV
Description:
Join our faculty for a one-hour webinar as they discuss the pandemic’s impact on breast surgery. Jay Harness, MD will moderate a panel discussion with Shawna Willey, MD, Beth DuPree, MD, and William Scarlett, DO, as they exchange ideas and reflect on experiences around COVID-19 and the future of breast surgery. We encourage audience participation, discussion, and questions at the end. Please join us for an informative, interactive webinar.
Moderator:
- Jay Harness, MD
Speakers:
- Beth DuPree, MD
- William Scarlett, DO
- Shawna Willey, MD
For More Information:
Learn about PLASMABLADE™, Precise Soft Tissue Dissection Devices, or call 1‑866‑777‑9400.
Myriad Genetics, Inc.
Personalizing Breast Cancer Risks Beyond BRCA. riskScore®: Using the Next Generation of Risk Models for a More Precise and Personalized Cancer Risk
Description:
We will discuss how riskScore® is a precision medicine tool clinically validated to predict a woman’s risk of developing breast cancer. We will illustrate how it analyzes family history, personal clinical risk factors, and over 80 well-studied genetic markers to predict the risk of developing breast cancer over the next 5 years and remaining lifetime. In addition, we will cover possible advances such as expanding its availability to all ancestries and leveraging it to refine the risk for mutation carriers.
Brochure:
Program Objectives:
- Describe how riskScore® analyzes over 80 well-studied genetic markers and combined with the Tyrer-Cuzick model estimates a woman’s risk for developing breast cancer
- Learn how the model was validated and can be utilized in clinic today
- Summarize how the utilization of polygenic risk scores significantly modifies the risk of patients who carry a mutation
Speaker:
- Thomas Slavin, MD, FACMG, DABCC
SVP, Medical Affairs - Oncology | Myriad Genetics, Inc.
PeerView Institute
The Era of Immuno-Oncology in TNBC: Navigating Evidence in Early-Stage & Advanced Disease, Practicalities of Integration, and Implications for Breast Surgeons
Description:
Immunotherapy has become a new pillar in the treatment arsenal for advanced triple-negative breast cancer (TNBC), and accumulating evidence is supporting its expansion into earlier disease stages as well. To make the most of this therapeutic approach as a component of multimodal management of patients, especially in curative intent settings, it is increasingly more important for breast surgeons, medical oncologists, radiation oncologists, pathologists, and other healthcare professionals to collaborate and coordinate the care of patients with TNBC.
This PeerView Live webcast provides up-to-date information and multidisciplinary perspectives on the current and emerging roles of immune checkpoint inhibitors and combinations throughout the disease continuum of TNBC, as well as practical guidance for optimal integration of these therapies into clinical practice, focusing on the most important implications for breast surgeons.
For More Information:
Contact PeerView at 1‑877‑833‑6141 or live@PeerView.com.